Supplementary Fig. 1 from A Phase I Study of Continuous Oral Dosing of OSI-906, a Dual Inhibitor of Insulin-Like Growth Factor-1 and Insulin Receptors, in Patients with Advanced Solid Tumors

Igor Puzanov, Colin R. Lindsay, Laura Goff, Jeff Sosman,Jill Gilbert,Jordan Berlin,Srinivasu Poondru, Ronit Simantov, Rich Gedrich, Andrew Stephens,Emily Chan, T.R. Jeffry Evans

crossref（2023）

Cited 0|Views0

No score

Abstract

Supplementary Fig. 1. Patient disposition.

Translated text

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined